CC-95251
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CC-95251, covering 2024-09-19 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndromes [Phase 1]